The current status of inpatient cancer rehabilitation provided by designated cancer hospitals in Japan.


Journal

Japanese journal of clinical oncology
ISSN: 1465-3621
Titre abrégé: Jpn J Clin Oncol
Pays: England
ID NLM: 0313225

Informations de publication

Date de publication:
01 Jul 2021
Historique:
received: 05 03 2021
accepted: 26 04 2021
pubmed: 15 5 2021
medline: 8 7 2021
entrez: 14 5 2021
Statut: ppublish

Résumé

This survey was conducted to clarify the current status of inpatient cancer rehabilitation provided by designated cancer hospitals in Japan. A survey questionnaire was sent to 427 designated cancer hospitals in Japan. Information was sought regarding whether inpatient cancer rehabilitation was provided by the center, and if so, whether respondents regarded such provision as satisfactory. Responses were obtained from 235/427 surveyed institutions (55.0%). Cancer rehabilitation was provided in inpatient settings by 97.4%. Two-thirds of respondents (67.7%) regarded inpatient cancer rehabilitation provision as still inadequate. The primary reasons claimed for this inadequacy were a lack of human resources, a lack of rehabilitation professionals with the requisite knowledge/skills and patients who would benefit from cancer rehabilitation present but not prescribed. The total number of rehabilitation staff was identified as associated factor of inadequate inpatient cancer rehabilitation in multivariate analysis (odds ratio = 0.979, 95% confidence interval = 0.96-1.00, P = 0.009). In order to provide adequate cancer rehabilitation, a sufficient supply of rehabilitation staff, education and recognition of the need for cancer rehabilitation within oncology units are necessary.

Identifiants

pubmed: 33989400
pii: 6275906
doi: 10.1093/jjco/hyab070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1094-1099

Subventions

Organisme : Cancer Research Institute
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Auteurs

Takuya Fukushima (T)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Tetsuya Tsuji (T)

Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan.

Noriko Watanabe (N)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Takuro Sakurai (T)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Aiko Matsuoka (A)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Kazuhiro Kojima (K)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Sachiko Yahiro (S)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Mami Oki (M)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Yusuke Okita (Y)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Shota Yokota (S)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Jiro Nakano (J)

Department of Physical Therapy, Kansai Medical University, Osaka, Japan.

Shinsuke Sugihara (S)

Department of Orthopedic Oncology and Rehabilitation, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.

Hiroshi Sato (H)

Department of Gastroenterological Surgery, Saitama International Medical Center, Saitama Medical University, Saitama, Japan.

Juichi Kawakami (J)

Department of Rehabilitation Medicine, Shiga Prefectural Rehabilitation Center, Shiga, Japan.

Hitoshi Kagaya (H)

Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Aichi, Japan.

Akira Tanuma (A)

Department of Rehabilitation Medicine, Juntendo University Shizuoka Hospital, Shizuoka, Japan.

Ryuichi Sekine (R)

Department of Pain and Palliative Care, Kameda Medical Center, Chiba, Japan.

Keita Mori (K)

Department of Clinical Research Center, Shizuko Cancer Center, Shizuoka, Japan.

Sadamoto Zenda (S)

Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.

Akira Kawai (A)

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH